BSX (STOCKS)
Boston Scientific Corp.
$63.000100
+1.210100 (+1.96%)
Prev close: $61.790000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael F. Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $93,852.27M
- Employees
- 53,000
- P/E (TTM)
- 31.87
- P/B (TTM)
- 3.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $20.07B |
| Benefits Costs and Expenses | $16.69B |
| Cost Of Revenue | $6.22B |
| Costs And Expenses | $16.69B |
| Gross Profit | $13.85B |
| Operating Expenses | $10.24B |
| Selling, General, and Administrative Expenses | $6.89B |
| Other Operating Expenses | $3.35B |
| Operating Income/Loss | $3.61B |
| Income/Loss From Continuing Operations After Tax | $2.89B |
| Income/Loss From Continuing Operations Before Tax | $3.39B |
| Income Tax Expense/Benefit | $493.00M |
| Income Tax Expense/Benefit, Current | $505.00M |
| Income Tax Expense/Benefit, Deferred | -$12.00M |
| Interest Expense, Operating | $349.00M |
| Net Income/Loss | $2.89B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$6.00M |
| Net Income/Loss Attributable To Parent | $2.90B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.90B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.96 |
| Diluted Earnings Per Share | $1.94 |
| Basic Average Shares | 1,480,400,000 |
| Diluted Average Shares | 1,494,500,000 |
| Assets | $43.67B |
| Current Assets | $8.79B |
| Inventory | $2.94B |
| Other Current Assets | $5.85B |
| Noncurrent Assets | $34.88B |
| Fixed Assets | $4.04B |
| Intangible Assets | $7.02B |
| Other Non-current Assets | $23.82B |
| Liabilities | $19.20B |
| Current Liabilities | $5.44B |
| Accounts Payable | $1.14B |
| Wages | $1.43B |
| Other Current Liabilities | $2.87B |
| Noncurrent Liabilities | $13.76B |
| Equity | $24.47B |
| Equity Attributable To Noncontrolling Interest | $239.00M |
| Equity Attributable To Parent | $24.23B |
| Liabilities And Equity | $43.67B |
| Net Cash Flow From Operating Activities | $4.53B |
| Net Cash Flow From Operating Activities, Continuing | $4.53B |
| Net Cash Flow From Investing Activities | -$2.64B |
| Net Cash Flow From Investing Activities, Continuing | -$2.64B |
| Net Cash Flow From Financing Activities | -$395.00M |
| Net Cash Flow From Financing Activities, Continuing | -$395.00M |
| Exchange Gains/Losses | $42.00M |
| Net Cash Flow | $1.54B |
| Net Cash Flow, Continuing | $1.50B |
| Comprehensive Income/Loss | $2.02B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $6.00M |
| Comprehensive Income/Loss Attributable To Parent | $2.01B |
| Other Comprehensive Income/Loss | -$872.00M |